- KeyBank Expands Commercial Banking Teams in Chicago and Southern California to Serve the Middle Market
- Provident Expands Commercial Lending Team as Part of Regional Growth Strategy for Eastern Pennsylvania
- Appraisers See a Mixed Picture for Valuations
- SLR Business Credit Adds Mark J. Simshauser as Senior Vice President Supporting Growth in Northeast US
- Bob Seidenberger Joins Franklin Capital as VP of Sales
Wingspire Capital Provides $40 Million Senior Secured Credit Facility to Theragenics Corporation
November 10, 2021
By Wingspire Capital
ATLANTA – NOV. 10, 2021 — Wingspire Capital LLC (“Wingspire”) is pleased to announce a $40 million senior secured credit facility provided to Theragenics Corporation, a developer and manufacturer of innovative medical devices.
The transaction included a $20 million revolving line of credit and a $20 million term loan, with the proceeds used to refinance existing debt and fund ongoing working capital and general corporate needs.
Now in its 40th year in business, Theragenics is a global leader in the manufacture and sale of brachytherapy “seeds” to treat prostate and other cancers. The Buford, Georgia-based company has also expanded into the manufacture and sale of products for interventional radiology, interventional cardiology, vascular surgery and wound closure. Theragenics product development capabilities focus on oncology and interventional markets.
“Wingspire Capital worked closely with the leadership team at Theragenics to understand their debt structure, working capital and corporate finance goals, and we created a senior secured credit facility that meets their exact needs,” said David Wisen, Founder & CEO of Wingspire Capital.
Frank Tarallo, CEO of Theragenics, commented, “Wingspire developed an understanding of our business, and provided a customized credit facility designed to support our strategic goals and objectives. Wingspire is an important strategic partner for Theragenics as we look forward to our future growth.”
ABOUT WINGSPIRE CAPITAL
Wingspire Capital is a middle market-focused, specialty finance firm that provides asset-backed credit facilities to businesses across all industries. Our depth of experience across all debt products and industries enables our firm to be creative and flexible in our approach, and the lender of choice for companies across all stages of growth and complexity. The commitments for our credit facilities range in size from $20 to $200 million.
Wingspire is a portfolio company of Owl Rock Capital Corporation (NYSE: ORCC), which is externally managed by Owl Rock Capital Advisors LLC, an SEC-registered investment adviser. Owl Rock is a division of Blue Owl Capital (NYSE: OWL), an alternative asset manager with approximately $62 billion of assets under management as of June 30, 2021. For further information, visit wingspirecapital.com.
